FDA Approves Ebola Vaccine For USe And Distribution In United States - Forbes | Canada News Media
Connect with us

Health

FDA Approves Ebola Vaccine For USe And Distribution In United States – Forbes

Published

 on


On Thursday, the FDA announced the approval of the Ebola vaccine, Ervebo, for use in adults aged 18 and older. This follows the approval of the vaccine in Europe in November. Although Ebola is rare in the U.S., the vaccine’s approval will help in world-wide efforts to prevent future Ebola outbreaks and deaths. 

Ervebo’s U.S. approval is based on results from a study conducted between 2014-2016 during an Ebola outbreak in Guinea. These study results showed that the vaccine was nearly 100% effective in preventing patients from contracting Ebola with symptom onset greater than 10 days after vaccination. In addition, the vaccine was tested in Liberia, Sierra Leone, Canada, Spain and the U.S., with similar results. The approval was granted to Merck & Co., Inc.

The vaccine is administered as a single-dose injection that contains a protein from the virus. The most commonly reported side effects were pain, swelling and redness at the injection site, as well as headache, fever, joint and muscle aches and fatigue.

“Today’s approval is an important step in our continuing efforts to fight Ebola in close coordination with our partners across the U.S. Department of Health and Human Services, as well as our international partners, such as the World Health Organization,” said Anna Abram, FDA Deputy Commissioner for Policy, Legislation, and International Affairs, in an FDA statement. “These efforts, including today’s landmark approval, reflect the FDA’s unwavering dedication to leveraging our expertise to facilitate the development and availability of safe and effective medical products to address urgent public health needs and fight infectious diseases, as part of our vital public health mission.”

Ebola, formally known as Ebola virus disease (EVD) is caused by the Zaire ebolavirus. Although rare, the virus can cause serious and often deadly results. The first cases of the disease were noted in Africa in the 1970s, and since then several breakouts have caused thousands of deaths on the African continent. Since 2014 alone, there have been more than 28,000 cases and 11,000 deaths from Ebola, the FDA statement reported. According to the World Health Organization, up to 90 percent of those infected with Ebola can die from the virus. 

The virus causes fever, fatigue, muscle pain, headaches and sore throat. This soon escalates to vomiting, diarrhea, rash, impaired kidney and liver function. In more extreme cases, patients will develop internal bleeding and eventually death may occur. 

The virus is also highly contagious and is transmitted through direct contact with bodily fluids, blood and tissue of infected people, or in some cases infected wild animals. For example, some of the cases in Africa are believed to have been begun through the consumption of infected animal meat, most notably bats. In addition, health workers who treat infected patients are at extremely high risk for contracting the virus themselves. 

Due to the extreme need for the vaccine, the FDA granted the vaccine’s application a Priority Review and a Tropical Disease Priority Review Voucher, as well as a Breakthrough Therapy designation, in the hopes to expedite the drug’s development. 

Let’s block ads! (Why?)



Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Bizarre Sunlight Loophole Melts Belly Fat Fast!

Published

 on

Product Name: Bizarre Sunlight Loophole Melts Belly Fat Fast!

Click here to get Bizarre Sunlight Loophole Melts Belly Fat Fast! at discounted price while it’s still available…

 

All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Bizarre Sunlight Loophole Melts Belly Fat Fast! is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked.

(more…)

Continue Reading

Trending

Exit mobile version